clinical trials

Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
JNJ
Janssen
clinical trials
Tremfya
psoriatic arthritis
Flag link:
Chi-Med Halts Phase III Study Early After Meeting Primary Endpoint
Chi-Med Halts Phase III Study Early After Meeting Primary Endpoint
BioSpace
Chi-Med
neuroendocrine tumors
clinical trials
surufatinib
Flag link:
Study Finds Hundreds of Medical Procedures To Be Ineffective
Study Finds Hundreds of Medical Procedures To Be Ineffective
Forbes
clinical trials
effectiveness
devices
Flag link:
Here's Why Savara Pharmaceuticals Collapsed Today
Here's Why Savara Pharmaceuticals Collapsed Today
Motley Fool
Savara Pharmaceuticals
molgradex
clinical trials
aPAP
Flag link:
Pfizer announces results from XELJANZ XR ORAL Shift study
Pfizer announces results from XELJANZ XR ORAL Shift study
Pharmaceutical Business Review
Pfizer
Xeljanz
clinical trials
rheumatoid arthritis
Flag link:
Dassault Puts Down $5.8B for Medidata Solutions
Dassault Puts Down $5.8B for Medidata Solutions
Medical Devices and Diagnostics Industry
Dassault Systemes
Medidata Solutions
M&A
clinical trials
devices
Flag link:
Novartis’ Cosentyx achieves primary and secondary endpoints in psoriatic arthritis study
Novartis’ Cosentyx achieves primary and secondary endpoints in psoriatic arthritis study
Pharmaceutical Business Review
Novartis
Cosentyx
clinical trials
psoriatic arthritis
Flag link:
CymaBay Therapeutics Stumbles in NASH Race, Shares Fall
CymaBay Therapeutics Stumbles in NASH Race, Shares Fall
Xconomy
CymaBay
NASH
clinical trials
seladelpar
Flag link:
Novavax still plans to push RSV vaccine to market after failed trial
Novavax still plans to push RSV vaccine to market after failed trial
Bizjournals
Novavax
RSV
clinical trials
vaccines
ResVax
Flag link:
Here's Why Arrowhead Pharmaceuticals Surged 31.9% in May
Here's Why Arrowhead Pharmaceuticals Surged 31.9% in May
Motley Fool
Arrowhead Pharmaceuticals
clinical trials
JNJ
hepatitis B
Flag link:
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Sanofi's Soliqua Edges Out Competitors in Blood Sugar Control Trial
Biopharma Dive
Sanofi
diabetes
ADA
Soliqua
clinical trials
Flag link:
Janssen Hopes to Improve Communication with Clinical Trial Patients Through New Program
Janssen Hopes to Improve Communication with Clinical Trial Patients Through New Program
BioSpace
Janssen
clinical trials
patients
Flag link:
Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show
Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show
BioSpace
Povention Bio
clinical trials
type 1 diabetes
ADA
immunotherapy
Flag link:
Aptinyx's lead drug makes cut in small fibromyalgia trial, setting the stage for larger chronic pain study
Aptinyx's lead drug makes cut in small fibromyalgia trial, setting the stage for larger chronic pain study
Endpoints
Aptinyx
clinical trials
fibromyalgia
NYX-2925
Flag link:
ADA: AstraZeneca's Farxiga scores in kidney outcomes study
ADA: AstraZeneca's Farxiga scores in kidney outcomes study
Fierce Pharma
AstraZeneca
ADA
Farxiga
clinical trials
renal disease
Flag link:
Celiac Disease Cure? ImmusanT Tests Nexvax2 in Clinical Trials
Celiac Disease Cure? ImmusanT Tests Nexvax2 in Clinical Trials
Xtalks
ImmusanT
celiac disease
Nexvax2
clinical trials
gluten
Flag link:
With industry's growing kidney moment, Everest begins building kidney portfolio
With industry's growing kidney moment, Everest begins building kidney portfolio
BioCentury
Everest Medicines
Calliditas
Nefecon
clinical trials
IgA nephropathy
kidney disease
Flag link:
FDA's Draft Guidance Proposes Ways to Increase Patient Diversity in Clinical Trials
FDA's Draft Guidance Proposes Ways to Increase Patient Diversity in Clinical Trials
BioSpace
FDA
clinical trials
diversity
Flag link:
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
BioSpace
Astex
Otsuka
clinical trials
ASTX727
myelodysplastic syndrome
CMML
Flag link:
NeRRe hopes to advance cough candidate despite Phase II miss
NeRRe hopes to advance cough candidate despite Phase II miss
BioCentury
NeRRe
orvepitant
clinical trials
chronic cough
Flag link:

Pages